Sundrug Co.,Ltd.
Sundrug Co.,Ltd. (SDGCF) Revenue
Annual & quarterly revenue history · segment & region breakdown
SDGCF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsSundrug Co.,Ltd. trailing twelve-month (TTM) revenue is $847B, an increase of 5.74% year-over-year from $848B in FY2026.
Revenue trend
2026 – 2007 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2026-03-31 | $848B | +$46.00B | +5.74% |
| 2025-03-31 | $802B | +$50.03B | +6.66% |
| 2024-03-31 | $752B | +$61.31B | +8.88% |
| 2023-03-31 | $690B | +$41.73B | +6.43% |
| 2022-03-31 | $649B | +$14.42B | +2.27% |
| 2021-03-31 | $634B | +$628.59B | +10984.55% |
| 2020-03-31 | $5.72B | +$0.41B | +7.71% |
| 2019-03-31 | $5.31B | +$0.01B | +0.15% |
| 2018-03-31 | $5.31B | +$0.56B | +11.88% |
| 2017-03-31 | $4.74B | +$0.26B | +5.80% |
Compare revenue vs peers
Medical - PharmaceuticalsCompare SDGCF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Sundrug Co.,Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Sundrug Co.,Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in JPY.
Data sourced from Sundrug Co.,Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
SDGCF revenue · 4 questionsSDGCF's trailing twelve-month (TTM) revenue is $847B. That is an increase of 5.74% year-over-year from $848B in FY2026.
▸ Source: FMP · Sundrug Co.,Ltd. SEC filings · GAAP · Sundrug Co.,Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026